Scientists have discovered that two widely available prescription drugs restore partial cellular folding, trafficking, and function to a variety of mutant enzymes responsible for three distinct lysosomal storage diseases, maladies involving multiple organ system failure. This discovery may increase treatment options for inherited metabolic disease patients.
More...